Addendum: ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma

PDF  |  How to cite

Oncotarget. 2023; 14:515-515. https://doi.org/10.18632/oncotarget.28448

Metrics: PDF 395 views  |   ?  

Eric I. Marks1,*, Sahithi Pamarthy2,*, Don Dizon1, Ari Birnbaum1, Evgeny Yakirevich3, Howard Safran1 and Benedito A. Carneiro1

1Division of Hematology, Oncology and Blood and Marrow Transplantation, Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Los Angeles, CA, USA
2Atrin Pharmaceuticals, Pennsylvania Biotechnology Center, Doylestown, PA, USA
3Department of Pathology, Lifespan Cancer Institute, Warren-Alpert Medical School of Brown University, Providence, RI, USA
*These authors contributed equally to this work

Published: May 26, 2023

Copyright: © 2023 Marks et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: Informed patient consent to an IRB-approved research protocol was obtained.

Original article: Oncotarget. 2019; 10:245-251. DOI: https://doi.org/10.18632/oncotarget.26521.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28448